Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concomitant Radiochemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01245959
What this trial is testing

Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 476
Not applicableActive Not RecruitingNCT07605507
What this trial is testing

Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer

Who this might be right for
Cervical Cancer
Siriraj Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03579004
What this trial is testing

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsSquamous Cell CarcinomaConcurrent Chemoradiotherapy
Mona Frolova 48
Not applicableStudy completedNCT07050472
What this trial is testing

Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Who this might be right for
Small-cell Lung Cancer
Anhui Shi, MD 45
Large-scale testing (Phase 3)Study completedNCT01540136
What this trial is testing

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 402
Large-scale testing (Phase 3)Study completedNCT04026412
What this trial is testing

Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 925
Early research (Phase 1)Study completedNCT04636632
What this trial is testing

Fosaprepitant for the Prevention of Nausea and Emesis During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07112833
What this trial is testing

A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527782
What this trial is testing

Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Hospital Universitario Doctor Peset 40
Testing effectiveness (Phase 2)UnknownNCT06569459
What this trial is testing

Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT05277688
What this trial is testing

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Ruijin Hospital 340
Testing effectiveness (Phase 2)Looking for participantsNCT07392320
What this trial is testing

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharangeal Cancer
Sun Yat-sen University 142
Testing effectiveness (Phase 2)Study completedNCT00601705
What this trial is testing

Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Case Comprehensive Cancer Center 61
Not applicableLooking for participantsNCT07305727
What this trial is testing

A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsCervical Cancer by FIGO Stage 2018
Centre Hospitalier Universitaire de Nīmes 120
Large-scale testing (Phase 3)UnknownNCT01598402
What this trial is testing

Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia

Who this might be right for
Head and Neck Cancer
Radboud University Medical Center 106
Testing effectiveness (Phase 2)Looking for participantsNCT07086456
What this trial is testing

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
SurufatinibTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University 80
Not applicableLooking for participantsNCT05401175
What this trial is testing

Hematopoietic Stem Cell-containing Autologous Blood Reinfusion for Bone Marrow Protection in Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 40
Early research (Phase 1)Study completedNCT01462474
What this trial is testing

Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT05298423
What this trial is testing

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 610
Large-scale testing (Phase 3)Ended earlyNCT01126216
What this trial is testing

Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Erlangen-Nürnberg Medical School 221
Next Page